Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +6,676 6,676
2020-01-09 Braunstein Scott Director Grant or award · Stock Option (Right to Buy) +15,737 15,737
2020-01-09 GARCEAU ROGER Director Grant or award · Stock Option (Right to Buy) +12,399 12,399
2020-01-09 GARCEAU ROGER Director Grant or award · Stock Option (Right to Buy) +10,491 10,491
2020-01-09 Solomon Michael Edward Director Grant or award · Stock Option (Right to Buy) +9,537 9,537
2020-01-09 Solomon Michael Edward Director Grant or award · Stock Option (Right to Buy) +2,861 2,861
2020-01-09 Solomon Michael Edward Director Grant or award · Stock Option (Right to Buy) +6,676 6,676
2020-01-09 Solomon Michael Edward Director Grant or award · Stock Option (Right to Buy) +10,491 10,491
2020-01-09 Zummo Jacqueline Sr. Vice President, Research Grant or award +28,613 28,613
2020-01-09 Zummo Jacqueline Sr. Vice President, Research Grant or award · Stock Option (Right to Buy) +19,075 19,075
2020-01-09 Zummo Jacqueline Sr. Vice President, Research Grant or award · Stock Option (Right to Buy) +9,537 9,537
2020-01-09 Zummo Jacqueline Sr. Vice President, Research Grant or award · Stock Option (Right to Buy) +9,537 9,537
2020-01-09 Casoy Julio Chief Medical Officer Grant or award · Stock Option (Right to Buy) +38,151 38,151
2020-01-09 Marshall Randall 10% owner Grant or award +654,020 654,020
2020-01-09 Shefferman Jesse CEO and President Grant or award +790,274 790,274

Page 17 of 17 · 335 trades